Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
May 30, 2024 02:35 ET
|
Nxera Pharma
Tokyo, Japan and Cambridge, UK, 30 May 2024 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) today announced that it expects to receive $4.6 million in milestone payments from Centessa...
Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimilar), at the European Hematology Association (EHA) Congress 2024
May 30, 2024 02:30 ET
|
Samsung Bioepis
Post-hoc analysis of Phase 3 study to highlight transfusion avoidance results of SB12 compared to reference eculizumab-treated groups INCHEON, Korea, May 30, 2024 (GLOBE NEWSWIRE) -- Samsung...
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’s disease cell therapy candidate bemdaneprocel
May 30, 2024 02:30 ET
|
BlueRock Therapeutics
Berlin, Germany and Cambridge, MA, USA, May 30, 2024 (GLOBE NEWSWIRE) -- Bayer AG and BlueRock Therapeutics LP, a clinical stage cell therapy company and wholly owned independently operated...
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
May 30, 2024 02:30 ET
|
Nxera Pharma
Expansion of existing partnership will utilize novel insights into causal biology within auto-immune disorders to identify novel targets for drug discovery Tokyo, Japan, Oxford and Cambridge,...
Survey shows that most Finns are satisfied with their own recycling habits - people aged over 65 have a more positive attitude towards recycling than young people
May 30, 2024 02:30 ET
|
Huhtamäki Oyj
HUHTAMÄKI OYJ PRESS RELEASE 30.5.2024 AT 09:30 EEST Over 80 per cent of Finnish consumers think that they recycle enough, and 40 per cent also say they would be willing to pay extra for...
Hoylu AB Publishes the Interim Report for January – March 2024
May 30, 2024 02:30 ET
|
Hoylu AB
FIRST THREE MONTHS 2024 Annual Recurring Revenue (ARR), including long-term service contracts, increased to MSEK 59.8 during the period, up 15% from Q1 2023.Revenue for the first three months of...
Combined General Meeting of June 20, 2024 - Availability of the preparatory documents
May 30, 2024 02:30 ET
|
INVENTIVA
Daix (France), Long Island City (New York, United States), May 30, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral...
Change of Company name and ticker symbol on Euronext Paris
May 30, 2024 02:30 ET
|
ALD SA
Paris, 30 May 2024 Following the approval by the Combined Shareholders Meeting of the change of the Company’s name from ALD to Ayvens on 14 May 2024, the Company announces that as of 3 June 2024,...
Statement of total voting rights and shares forming the company’s share capital as of May 13, 2024
May 30, 2024 02:30 ET
|
INVENTIVA
Article R. 22-10-23 of the French Commercial Code Market : Euronext ParisISIN code / Mnemo : FR0013233012 / IVAWeb site : www.inventivapharma.com Date Number of Shares Outstanding ...
Renewi announces sale of UK Municipal business to Biffa
May 30, 2024 02:01 ET
|
Renewi PLC
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION (EU) NO 596/2014 (“MAR”) AND MAR WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT...
- May 30, 2024 01:30 ET Moody’s selects TomTom location data for its risk management solutions
- May 30, 2024 01:00 ET WHO Misinformation ‘Harming Public Health and Turning African Smokers Away From Lifesaving Vapes’ – New Poll